Mark Preston

Chief Technology Officer

Mark has extensive expertise in biotech, data analytics, and cloud technologies. As CTO, Mark leads the development of Lodestar DX overseeing technological innovation, scalability, and compliance.

Mark’s early career includes experience in embedded systems and devices at Sony and Panasonic, working on networking hardware, mobile phones, and microscopes. His later work in app development, AI-driven insights, and workflow optimization enabled him to deliver scalable, secure, and compliant solutions for start-ups and global organizations, including vaccine manufacturers.

As a Founder and Managing Director of consultancy firm Prismea, Mark helps biotech companies innovate with data analytics, cloud systems, and regulatory compliance as well as navigating medical regulatory frameworks with organizations such as the MHRA.

More Team Members

Martyn Lewis

Chief Executive Officer

Dr Emma Hayhurst

Chief Operating Officer and co-founder

Mr Bob Yang

Chief Medical Officer

Laurence Tisi

Non-Executive Director

Dr Jeroen Nieuwland

Chief Scientific Officer

Dr Gary Dowthwaite

Operations Manager

Start a conversation with Llusern

Llusern is developing treatment-directing diagnostics for high-volume healthcare challenges, starting with rapid molecular UTI testing. To learn more about the company, the product and the opportunity ahead, speak to the Llusern team.

Speak to the team